Peripartum cardiomyopathy: an obstetric review
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20170364Keywords:
BNP, PPCM, ProlactinAbstract
Peripartum cardiomyopathy (PPCM) is a rare and potentially fatal form of systolic heart failure which presents in later months of pregnancy and post-partum. Incidence varies over geography and ethnicity. It is highest in the African tribes of Hausa and Fulani. The incidence in the United States ranges from 1 in 1500-7500 births. Risk factors include advanced maternal age, multiparity, preeclampsia, multifetal gestation and African descent. Various etiologies such as viral myocarditis, abnormal immune and hemodynamic response to pregnancy, inflammatory mediation and genetic susceptibility have been proposed. Of late, the role of abnormal prolactin metabolism and resulting myocardial toxicity have been explored and bromocriptine has shown promise as a potential treatment option. Medical management is similar to other causes of systolic heart failure, except that ACE inhibitors and angiotensin receptor blockers are avoided in pregnancy. Complications include cardiac arrhythmias, thromboembolism and refractory heart failure can occur. Maternal deaths are not uncommon.Metrics
References
Ritchie C. Clinical contribution to the pathology, diagnosis and treatment of certain chronic diseases in the heart. Edinburgh Med Surg. 1849;2:333-5.
Porak C. De l’influence reciproque de la grossesse et des maladies du Couer, thesis, Paris. 1880.
Gouley BA, McMillan TM, Bellet S. Idiopathic myocardial degeneration associated with pregnancy and especially the puerperium. Am J Med Sci. 1937;194:185-99.
Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010;12(8):767-8.
Hibbard JU, Lindheimer M, Lang RM. A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Obstet Gynecol. 1999;94(2):311-6.
Isezuo SA, Abubakar SA. Epidemiologic profile of peripartum cardiomyopathy in a tertiary care hospital. Ethn Dis. 2007;17(2):228-33.
Gentry MB, Dias JK, Luis A, Patel R, Thornton, Reed GL. African-American women have a higher risk for developing peripartum cardiomyopathy. J Am Coll Cardiol. 2010;55(7):654-9.
Witlin AG, Mabie WC, Sibai BM. Peripartum cardiomyopathy: an omnious diagnosis. Am J Obstet Gynecol. 1997;176(1 Pt 1):182-8.
Chapa JB, Heiberger HB, Weinert L, DeCara J, Lang R, Hibbard JU. Prognostic value of echocardiography in peripartum cardiomyopathy. Obstet Gynecol. 2005;105(6):1303-8.
Mielniczuk LM, Williams L, Davis DR, Tang AS, Lemery R, Green MS, et al. Frequency of peripartum cardiomyopathy. Am J Cardiol. 2006;97(12):1765-8.
Brar SS, Khan SS, Sandhu GK, Jorgensen MB, Parikh N, Hsu JW, et al. Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am J Cardiol. 2007;100(2):302-4.
Kao DP, Hsich E, Lindenfeld J. Characteristics, adverse events, and racial differences among delivering mothers with peripartum cardiomyopathy. JACC Heart Fail. 2013;1(5):409-16.
Fett JD, Christie LG, Carraway RD, Murphy JG. Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc. 2005;80(12):1602-6.
Pandit V, Shetty S, Kumar A, Sagir A. Incidence and outcome of peripartum cardiomyopathy from a tertiary hospital in South India. Trop Doct. 2009;39(3):168-9.
Gunderson EP, Croen LA, Chiang V, Yoshida CK, Walton D, Go AS. Epidemiology of peripartum cardiomyopathy: incidence, predictors, and outcomes. Obstet Gynecol. 2011;118(3):583-91.
Elkayam U. Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. J Am Coll Cardiol. 2011;58(7):659-70.
Lampert MB, Hibbard J, Weinert L, Briller J, Lindheimer M, Lang RM. Peripartum heart failure associated with prolonged tocolytic therapy.Am J Obstet Gynecol. 1993;168(2):493-5.
Bello N, Rendon IS, Arany Z. The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis. J Am Coll Cardiol. 2013;62(18):1715-23.
Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007;128(3):589-600.
Patten IS, Rana S, Shahul S, Rowe GC, Jang C, Liu L, et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature. 2012;485(7398):333-8.
Sliwa K, Mebazaa A. Possible joint pathways of early pre-eclampsia and congenital heart defects via angiogenic imbalance and potential evidence for cardio-placental syndrome. Eur Heart J. 2014;35(11):680-2.
Sanderson JE, Olsen EG, Gate J D. Peripartum heart disease: an endomyocardial biopsy study. Br Heart J. 1986;56:285-91.
O'Connell JB, Costanzo-Nordin MR, Subramanian R, Robinson JA, Wallis DE, Scanlon PJ, et al. Peripartum cardiomyopathy: clinical, hemodynamic, histologic and prognostic characteristics. J Am Coll Cardiol. 1986;8(1):52-6.
Bultmann BD, Klingel, K, Nabauer M, Wallwiener D, Kandolf R. High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol. 2005;193(2):363-5.
Rizeq MN, Rickenbacher PR, Fowler MB, Billingham ME. Incidence of myocarditis in peripartum cardiomyopathy. Am J Cardiol. 1994;74(5):474-7.
Sliwa K, Skudicky D, Bergemann A, Candy G, Puren A, Sareli P. Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. J Am Coll Cardiol. 2000;35(3):701-5.
Sliwa K, Förster O, Libhaber E, Fett JD, Sundstrom JB, Hilfiker-Kleiner D, et al. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J. 2006;27(4):441-6.
Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM , Hosenpud JD, et al. Peripartum cardiomyopathy. National Heart Lung and Blood Institute and Office of Rare Diseases (National Institutes of Health) Workshop recommendations and review. JAMA. 2000;283(9)-1183-4.
Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet. 2006;368(9536):687-93.
Warraich RS, Sliwa K, Damasceno A, Carraway R, Sundrom B, Arif G, et al. Impact of pregnancy-related heart failure on humoral immunity: clinical relevance of G3-subclass immunoglobulins in peripartum cardiomyopathy. Am Heart J. 2005;150(2):263-9.
Ramaraj R, Sorrell VL. Peripartum cardiomyopathy: causes, diagnosis, and treatment. Clev Clin J Med 2009;76(5):289-96.
Van Spaendonck-Zwarts KY, van Tintelen JP, van Veldhuisen DJ, van der Werf R, Jongbloed JD, Paulus WJ, et al. Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation 2010;121:2169-75.
Anderson JL, Horne BD. Birthing the genetics of peripartum cardiomyopathy. Circulation 2010;121(20):2157-9.
Moioli M, Menada MV, Bentivoglio G, Ferrero S. Peripartum cardiomyopathy. Arch Gynecol Obstet. 2010;281(2):183-8.
Cole WC, Mehta JB, Roy TM, Downs CJ. Peripartum cardiomyopathy: echocardiogram to predict prognosis. Tennessee Medicine 2001;94(4):135-8.
Carlson KM, Browning JE, Eggleston MK, Gherman RR. Peripartum cardiomyopathy presenting as lower extremity arterial thromboembolism. A case report. J Reprod Med Obstet Gynecol. 2000;45(4):351-3.
Bennani SL, Loubaris M, Lahlou I, Haddour N, Badidi M, Bouhouch R, et al. Postpartum cardiomyopathy revealed by acute lower limb ischemia. Ann Cardiol Angeiol (Paris). 2003;52(6):382-5.
Box LC, Hanak V, Arciniegas JG. Dual coronary emboli in peripartum cardiomyopathy. Tex Heart Inst J. 2004;31(4):442-4.
Lasinska-Kowara M, Dudziak M, Suchorzewska J. Two cases of postpartum cardiomyopathy initially misdiagnosed for pulmonary embolism. Can J Anaesth. 2001;48(8):773-7.
Diao M, Diop IB, Kane A, Camara S, Sarr M, Ba SA, Diouf SM.Electrocardiographic recording of long duration (Holter) of 24 hours during idiopathic cardiomyopathy of the peripartum. Arch Mal Coeur Vaiss. 2004;97(1):25-30.
Bertrand E, Langlois J, Renambot J, Chauvet L, Ekra A. La myocardiopathie du post-partum : à propos de 25 cas. Arch Mal Coeur Vaiss. 1977;70(2):169-78.
Fadouach S, Matar N, Meziane M, Tahiri A, Chraibi N. Syndrome de Meadows: cardiomyopathie du pèripartum. Rev Fr Gynecol Obstet 1994;89(6);335-6.
Lampert MB, Lang RM. Peripartum cardiomyopathy. Am Heart J. 1995;130(4):860-70.
Blauwet LA, Cooper LT. Diagnosis and management of peripartum cardiomyopathy. Heart. 2011;97(23):1970-81.
Forster O, Hilfiker-Kleiner D, Ansari AA, Sundstrom JB, Libhaber E, Tshani W, et al. Reversal of IFN-gamma, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy. Eur J Heart Fail. 2008;10(9):861-8.
Demakis JG, Rahimtoola SH, Sutton GC, Meadows WR, Szanto PB, Tobin JR, et al. Natural course of peripartum cardiomyopathy. Circulation. 1971;44(5):1053-61.
Saltzberg MT, Szymkiewicz S, Bianco NR. Characteristics and outcomes of peripartum versus nonperipartum cardiomyopathy in women using a wearable cardiac defibrillator. J Card Fail. 2012;18(1):121-7.
Sliwa K, Blauwet L, Tibazarwa K, Libhaber E, Smedema JP, Becker A, et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation. 2010;121(13):1465-73.
Bozkurt B, Villaneuva FS, Holubkov R, Tokarczyk T, Alvarez RJ Jr, MacGowan GA, et al. Intravenous immune globulin in the therapy of peripartum cardiomyopathy. J Am Coll Cardiol. 1999;34(1):177-80.
Murali S, Baldisseri MR. Peripartum cardiomyopathy. Crit Care Med. 2005;33(10)Suppl:340-6.
Amos A, Jaber WA, Russell SD. Improved outcomes in peripartum cardiomyopathy with contemporary. Am Heart J. 2006;152(3):509-13.
Goland S, Modi K, Bitar F. Clinical profile and predictors of complications in peripartum cardiomyopathy. J Card Fail. 2009;15:645-50.
Elkayam U, Akhter, MW, Singh H, Khan S, Bitar F, Hameed A, et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation. 2005;111(16):2050-5.
Pyatt RJ, Dubey G. Peripartum cardiomyopathy: current understanding, comprehensive management review and new developments. Postgrad Med J. 2011;87(1023):34-9.
Downloads
Published
How to Cite
Issue
Section
